COMMUNIQUÉS West-GlobeNewswire

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/04/2025 - 22:05

REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted an inducement award [...]

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04/04/2025 - 22:05

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX ), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, [...]

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/04/2025 - 22:01

NAARDEN, the Netherlands and MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/04/2025 - 22:00

WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology [...]

American Nurses Enterprise Names New Chief Nursing Officer

04/04/2025 - 21:13

Dr. Bradley Goettl, DNP, DHA, RN, FNP-C, FAAN appointed to enterprise leadership role SILVER SPRING, MD, April 04, 2025 (GLOBE NEWSWIRE) -- The American Nurses Enterprise, which includes the American Nurses Association [...]

Canadian Pet Population Survey Highlights the Importance of Access to Veterinary Care

04/04/2025 - 19:18

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- The latest findings from the 2024 Canadian Pet Population Survey reveal significant insights into the pet ownership landscape in Canada. Conducted by Léger, a leading Canadian [...]

Le sondage sur la population des animaux de compagnie au Canada souligne l’importance de l’accès aux soins vétérinaires

04/04/2025 - 19:18

TORONTO, 04 avr. 2025 (GLOBE NEWSWIRE) -- Les derniers résultats du sondage sur la population canadienne des animaux de compagnie 2024 révèlent des informations importantes sur les propriétaires d’animaux de compagnie [...]

Energetic Harmony Expands Holistic Stress Relief Services with Emotion Code for Professionals Facing Chronic Stress or Past Trauma

04/04/2025 - 17:31

TAMPA BAY, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Energetic Harmony ℠, a leader in holistic stress relief, proudly announces the expansion of its services to include Emotion Code —a powerful modality specifically [...]

Better Choice Company Chairman Provides Shareholder Update on SRx Health Acquisition and Comments on Recent Debt-to-Equity Transaction

04/04/2025 - 16:44

TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, Chairman, Michael Young, today provides [...]

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

04/04/2025 - 15:40

LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today [...]

Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider

04/04/2025 - 15:21

Oslo, Norway, 4 April, 2025 - Reference is made to the stock exchange notice published by Zelluna ASA (the " Company ") on 27 March 2025 regarding key information on the reverse share split at a ratio of 10:1. Radforsk [...]

NurExone Biologic Announces U.S. Uplisting Intention and Closes C$2.3 Million Private Placement

04/04/2025 - 15:16

TORONTO and HAIFA, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX, OTCQB: NRXBF, Germany: J90) (“ NurExone ” or the “ Company ”) is pleased to announce that, subject to TSX Venture Exchange [...]

Better Choice Company Signs Definitive Agreement for SRx Health Solutions to Convert CAD$4 Million in Debt to Equity

04/04/2025 - 15:15

TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, is pleased to announce that SRx Health Solutions, [...]

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

04/04/2025 - 14:30

EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for [...]

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

04/04/2025 - 14:30

Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology meeting Long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in focal onset seizures (FOS) [...]

Entourage Health Corp. Announces Closing of Plan of Arrangement

04/04/2025 - 14:20

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (the “ Company ” or “ Entourage ”) is pleased to announce the closing of the previously announced plan of [...]

Tr1X Awarded $8 Million CIRM Grant to Support TRX103 Phase 1/2a Clinical Trial for Graft-Versus-Host Disease

04/04/2025 - 14:00

SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the [...]

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

04/04/2025 - 14:00

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program [...]

Palvella Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference

04/04/2025 - 14:00

WAYNE, Pa., April 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat [...]